RecruitingPhase 3NCT05690841

FocaL Mass Drug Administration for Vivax Malaria Elimination

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Michelle Hsiang, MD
University of California, San Francisco
Intervention
Focal Mass Drug Administration (fMDA)(drug)
Enrollment
7530 target
Eligibility
All sexes
Timeline
2024 – 2027

Study locations (1)

Collaborators

Universidad Peruana Cayetano Heredia · PATH · Stanford University · Oxford University Clinical Research Unit Indonesia · Menzies School of Health Research · National Institute of Allergy and Infectious Diseases (NIAID)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05690841 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials